Allergan Aesthetics reveals insights on medical weight loss (MWL) and evolving patient expectations. The data shows how weight-loss treatments influence demand for aesthetic procedures. Medical weight loss treatments gain attention MWL programmes, including GLP-1 medications, help patients achieve significant weight reductions under medical supervision. These treatments are driving a new demographic seeking aesthetic care. Many patients experience midface volume loss, ...
The rising use of GLP-1 medications like semaglutide is creating a new trend in the aesthetic world: the “Ozempic face.” Many people who lose weight quickly notice that their faces lose volume, leading to sagging skin, hollow cheeks, and an older appearance. This side effect is now driving increased demand for aesthetic treatments, ranging from fillers to surgical facelifts. Understanding ...